HOLOGIC INC: The Company is Going Private

1. What happened?

Hologic, Inc. (ticker: HOLX) has cleared all regulatory hurdles to be acquired by private investment firms Blackstone and TPG Global. This all-cash deal is valued at approximately $28.5 billion. As part of the transition, long-time Chairman, President, and CEO Stephen P. MacMillan will retire effective upon the deal's closing.

2. When does this take effect?

The company filed the official announcement on April 6, 2026. The deal is set to close on or about April 7, 2026, which will be Hologic’s final day as a publicly traded company on the Nasdaq.

3. Why is this happening?

Following a strategic review that began in October 2025, Hologic’s leadership decided to move to a private model. By going private, the company aims to escape the pressure of meeting short-term quarterly earnings goals. Blackstone and TPG Global intend to deploy capital to accelerate research and development in Diagnostics, Breast Health, GYN Surgical, and Skeletal Health without the requirement of public financial reporting.

4. Why does this matter for you?

This deal represents a major shift for the medical technology sector. Under Stephen P. MacMillan’s 12-year tenure, Hologic evolved from a niche women’s health firm into a global leader, with revenue climbing from $2.5 billion in 2013 to over $4.1 billion last year and a stock price increase of 241%. MacMillan’s departure signals a new era; the incoming management team is expected to prioritize aggressive profit margins and potential divestitures of smaller business units to manage the debt associated with this buyout.

5. What this means for you

• Investors: If you hold HOLX shares, you will receive $92.50 in cash per share—a 22% premium over the average price prior to the deal announcement. This process is automatic; your brokerage will deposit the cash into your account within three business days of the closing.
• Customers: Hologic remains a primary provider of essential tools like the Genius™ 3D Mammography™ system and Panther® diagnostic platforms. While daily operations are expected to remain stable, be aware that pricing and service contracts may shift as the new owners focus on profitability.
• Employees: Private equity buyouts often involve restructuring to reduce costs. With a new CEO transition underway, expect a shift in focus toward internal efficiency and specific profit targets rather than public growth metrics.

6. What should you do now?

• Verify your account: Ensure your brokerage account is active and in good standing to receive your cash payout. If you hold physical paper stock certificates, contact the transfer agent, Computershare, immediately to facilitate your payment.
• Prepare for the transition: Once the market closes on April 7, 2026, HOLX will cease trading. The company will no longer hold quarterly earnings calls or release public financial reports. You will no longer be able to track their performance through standard market channels.
• Monitor leadership changes: While the company has not provided specific details on the new board’s long-term roadmap, keep an eye on industry news. The composition of the new leadership team will be the primary indicator of whether the company intends to pursue aggressive acquisitions or focus on streamlining existing operations.

Bottom Line: This is a straightforward exit for public shareholders. You don't need to take any action to receive your cash payout, but you should prepare for the fact that Hologic will soon disappear from your investment portfolio and public market tracking tools.